Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mechanisms of immune checkpoint inhibitors: insights into the regulation of circular RNAS involved in cancer hallmarks
Lingjiao Meng, Haotian Wu, Jiaxiang Wu, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 57

Showing 1-25 of 57 citing articles:

Emerging Therapeutic Strategies to Overcome Drug Resistance in Cancer Cells
Pankaj Garg, Jyoti Malhotra, Prakash Kulkarni, et al.
Cancers (2024) Vol. 16, Iss. 13, pp. 2478-2478
Open Access | Times Cited: 33
CD8+ T cell-based cancer immunotherapy
Yanxia Chen, Dingning Yu, Hui Qian, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 19
Advanced Polymeric Nanoparticles for Cancer Immunotherapy: Materials Engineering, Immunotherapeutic Mechanism and Clinical Translation
Wencong Jia, Ye Wu, Yujie Xie, et al.
Advanced Materials (2025)
Closed Access | Times Cited: 2
Circular RNAs in tumor immunity and immunotherapy
Wenjie Zhang, Xu Chen, Zhipeng Yang, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 9
Next-Generation Immunotherapy: Advancing Clinical Applications in Cancer Treatment
Pankaj Kumar Garg, Siddhika Pareek, Prakash Kulkarni, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 21, pp. 6537-6537
Open Access | Times Cited: 9
A Real-World Comparison of the Safety Profile for Immune Checkpoint Inhibitors in Oncology Patients
Abdulrahman Alwhaibi, Miteb Alenazi, Sultan Alghadeer, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 2, pp. 388-388
Open Access | Times Cited: 1
Drug‐Induced Liver Injury Associated With Emerging Cancer Therapies
Piotr Chodup, Sophia L. Samodelov, Michele Visentin, et al.
Liver International (2025) Vol. 45, Iss. 2
Open Access | Times Cited: 1
Promising Combinatorial Therapeutic Strategies against Non-Small Cell Lung Cancer
Prabhjot Kaur, Santosh Kumar Singh, Manoj K. Mishra, et al.
Cancers (2024) Vol. 16, Iss. 12, pp. 2205-2205
Open Access | Times Cited: 5
Predictive Biomarkers and Resistance Mechanisms of Checkpoint Inhibitors in Malignant Solid Tumors
Luciana Alexandra Pavelescu, Robert Mihai Enache, Oana Alexandra Roşu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9659-9659
Open Access | Times Cited: 5
Non‑coding RNA: A promising diagnostic biomarker and therapeutic target for esophageal squamous cell carcinoma (Review)
Longze Zhang, Yanyan Wang, Jianmei Gao, et al.
Oncology Letters (2024) Vol. 27, Iss. 6
Open Access | Times Cited: 4
Understanding the role of the gut microbiome in solid tumor responses to immune checkpoint inhibitors for personalized therapeutic strategies: a review
Mi Young Lim, Seungpyo Hong, Young‐Do Nam
Frontiers in Immunology (2025) Vol. 15
Open Access
Metformin as an immunomodulatory agent in enhancing head and neck squamous cell carcinoma therapies
Wenting Li, Naiming Liu, Mingwei Chen, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025) Vol. 1880, Iss. 2, pp. 189262-189262
Closed Access
Pathophysiological mechanisms of ARDS: a narrative review from molecular to organ-level perspectives
Kaihuan Zhou, Qianqian Qin, Junyu Lu
Respiratory Research (2025) Vol. 26, Iss. 1
Open Access
Immunological Landscape of Non-Melanoma Skin Neoplasms: Role of CTLA4+IFN-γ+ Lymphocytes in Tumor Microenvironment Suppression
Silvana Karabatić Knezović, Dora Knezović, Jelena Ban, et al.
Medicina (2025) Vol. 61, Iss. 2, pp. 330-330
Open Access
Personalization of Cancer Treatment: Exploring the Role of Chronotherapy in Immune Checkpoint Inhibitor Efficacy
Rosalyn M. Fey, Avery Billo, Terri Clister, et al.
Cancers (2025) Vol. 17, Iss. 5, pp. 732-732
Open Access
Spatial recognition and semi-quantification of epigenetic events in pancreatic cancer subtypes with multiplexed molecular imaging and machine learning
K Szymoński, Natalia Janiszewska, Kamila Sofińska, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Exploring Immune Checkpoint Inhibitors: Focus on PD-1/PD-L1 Axis and Beyond
Durre Aden, Samreen Zaheer, Niti Sureka, et al.
Pathology - Research and Practice (2025) Vol. 269, pp. 155864-155864
Closed Access
The Histomorphology to Molecular Transition: Exploring the Genomic Landscape of Poorly Differentiated Epithelial Endometrial Cancers
Thulo Molefi, Lloyd Mabonga, Rodney Hull, et al.
Cells (2025) Vol. 14, Iss. 5, pp. 382-382
Open Access
Digging Through the Complexities of Immunological Approaches in Emerging Osteosarcoma Therapeutics: A Comprehensive Narrative Review with Updated Clinical Trials
Consolato Sergi, Mervin Burnett, Eugeniu Jantuan, et al.
Biomedicines (2025) Vol. 13, Iss. 3, pp. 664-664
Open Access
Role of Soluble Cytokine Receptors in Gastric Cancer Development and Chemoresistance
Francesco Severini, Geppino Falco, Tiziana Notarangelo
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2534-2534
Open Access
Precision Medicine in High-Grade Serous Ovarian Cancer: Targeted Therapies and the Challenge of Chemoresistance
Sara Polajžer, Katarina Černe
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2545-2545
Open Access
NCOR2 represses MHC class I molecule expression to drive metastatic progression of breast cancer
Pavla Ticha, Jason J. Northey, Kelly Kersten, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Inflammation and cancer: molecular mechanisms and clinical consequences
Hikmet Akkız, Cem Şimşek, Deniz Balcı, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Immune Modulation and Immunotherapy in Solid Tumors: Mechanisms of Resistance and Potential Therapeutic Strategies
Suman Giri, Gopal Lamichhane, Jitendra Pandey, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 2923-2923
Open Access
Circular RNA in liver cancer research: biogenesis, functions, and roles
Jia‐Yi Wang, Congcong Zhang, Yinghui Zhang, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Page 1 - Next Page

Scroll to top